BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,374,000 | -28.2% | 35,549 | -30.8% | 0.19% | -9.4% |
| Q2 2022 | $7,484,000 | +4697.4% | 51,361 | +2313.6% | 0.21% | +2266.7% |
| Q2 2020 | $156,000 | -37.3% | 2,128 | -53.5% | 0.01% | 0.0% |
| Q4 2019 | $249,000 | +352.7% | 4,581 | +243.4% | 0.01% | +350.0% |
| Q3 2019 | $55,000 | -93.6% | 1,334 | -93.3% | 0.00% | -95.2% |
| Q2 2019 | $866,000 | +95.5% | 19,769 | +129.8% | 0.04% | +68.0% |
| Q1 2019 | $443,000 | +5437.5% | 8,603 | +3977.3% | 0.02% | – |
| Q3 2018 | $8,000 | -99.2% | 211 | -99.5% | 0.00% | -100.0% |
| Q1 2018 | $1,023,000 | – | 39,700 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |